Amphastar Pharmaceuticals, Inc. (Amphastar Pharmaceuticals), formerly known as the New Drug Research Center (NDRC), is an integrated specialty private pharmaceutical company that is engaged in the development, manufacture, marketing and sale of generic and proprietary injectable and inhalation products using new technologies and delivery systems. Overall, the company manufactures and sells about 67 generic injectable and inhalation products. Its lead products include primatene mist, amphadase, cortrosyn, lidocaine jelly, naloxone and phytonadione. Amphastar Pharmaceuticals has a pipeline of products and is wide open to partner its proprietary drug development pipeline and out-licensing its patented technologies. The company is headquartered at Rancho Cucamonga in California, the US.

Street: 
11570 6th Street
City: 
Rancho Cucamonga
Postcode: 
91730
Federal State : 
United States
WebSite: 
www.amphastar.com
Fax: 
1-909-9808296

Company Index Score

Current Index Score Historical Index Score
  • Amphastar Pharmaceuticals, Inc. currently scores 50 % in the index.
  • Amphastar Pharmaceuticals, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Amphastar Pharmaceuticals, Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets